These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17982133)

  • 1. Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow.
    Won D; Zhu SN; Chen M; Teichert AM; Fish JE; Matouk CC; Bonert M; Ojha M; Marsden PA; Cybulsky MI
    Am J Pathol; 2007 Nov; 171(5):1691-704. PubMed ID: 17982133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Function of Flow-Responsive Cis-DNA Elements of eNOS Gene: A Role for Chromatin-Based Mechanisms.
    Ku KH; Dubinsky MK; Sukumar AN; Subramaniam N; Feasson MYM; Nair R; Tran E; Steer BM; Knight BJ; Marsden PA
    Circulation; 2021 Aug; 144(5):365-381. PubMed ID: 33910388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation.
    Chan Y; Fish JE; D'Abreo C; Lin S; Robb GB; Teichert AM; Karantzoulis-Fegaras F; Keightley A; Steer BM; Marsden PA
    J Biol Chem; 2004 Aug; 279(33):35087-100. PubMed ID: 15180995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
    Grumbach IM; Chen W; Mertens SA; Harrison DG
    J Mol Cell Cardiol; 2005 Oct; 39(4):595-603. PubMed ID: 16099468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-atherosclerotic disturbed flow disrupts caveolin-1 expression, localization, and function via glycocalyx degradation.
    Harding IC; Mitra R; Mensah SA; Herman IM; Ebong EE
    J Transl Med; 2018 Dec; 16(1):364. PubMed ID: 30563532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PECAM-1 interacts with nitric oxide synthase in human endothelial cells: implication for flow-induced nitric oxide synthase activation.
    Dusserre N; L'Heureux N; Bell KS; Stevens HY; Yeh J; Otte LA; Loufrani L; Frangos JA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1796-802. PubMed ID: 15284089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene.
    Teichert AM; Miller TL; Tai SC; Wang Y; Bei X; Robb GB; Phillips MJ; Marsden PA
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1352-61. PubMed ID: 10749733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription.
    Chen W; Bacanamwo M; Harrison DG
    J Biol Chem; 2008 Jun; 283(24):16293-8. PubMed ID: 18397880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-linked kinase regulates vasomotor function by preventing endothelial nitric oxide synthase uncoupling: role in atherosclerosis.
    Herranz B; Marquez S; Guijarro B; Aracil E; Aicart-Ramos C; Rodriguez-Crespo I; Serrano I; Rodríguez-Puyol M; Zaragoza C; Saura M
    Circ Res; 2012 Feb; 110(3):439-49. PubMed ID: 22194624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation.
    Ramírez CM; Zhang X; Bandyopadhyay C; Rotllan N; Sugiyama MG; Aryal B; Liu X; He S; Kraehling JR; Ulrich V; Lin CS; Velazquez H; Lasunción MA; Li G; Suárez Y; Tellides G; Swirski FK; Lee WL; Schwartz MA; Sessa WC; Fernández-Hernando C
    Circulation; 2019 Jul; 140(3):225-239. PubMed ID: 31154825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase gene expression during murine embryogenesis: commencement of expression in the embryo occurs with the establishment of a unidirectional circulatory system.
    Teichert AM; Scott JA; Robb GB; Zhou YQ; Zhu SN; Lem M; Keightley A; Steer BM; Schuh AC; Adamson SL; Cybulsky MI; Marsden PA
    Circ Res; 2008 Jul; 103(1):24-33. PubMed ID: 18556578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle contraction induced arterial shear stress increases endothelial nitric oxide synthase phosphorylation in humans.
    Casey DP; Ueda K; Wegman-Points L; Pierce GL
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H854-H859. PubMed ID: 28801524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.
    Srinivasan S; Hatley ME; Bolick DT; Palmer LA; Edelstein D; Brownlee M; Hedrick CC
    Diabetologia; 2004 Oct; 47(10):1727-34. PubMed ID: 15490108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding.
    Davis ME; Grumbach IM; Fukai T; Cutchins A; Harrison DG
    J Biol Chem; 2004 Jan; 279(1):163-8. PubMed ID: 14570928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress.
    Mukohda M; Stump M; Ketsawatsomkron P; Hu C; Quelle FW; Sigmund CD
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H39-48. PubMed ID: 26566726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atheroprotective Flow Upregulates ITPR3 (Inositol 1,4,5-Trisphosphate Receptor 3) in Vascular Endothelium via KLF4 (Krüppel-Like Factor 4)-Mediated Histone Modifications.
    He M; Huang TS; Li S; Hong HC; Chen Z; Martin M; Zhou X; Huang HY; Su SH; Zhang J; Wang WT; Kang J; Huang HD; Zhang J; Chien S; Shyy JY
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):902-914. PubMed ID: 30917677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel.
    Tai SC; Robb GB; Marsden PA
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):405-12. PubMed ID: 14656742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
    Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
    J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2.
    Dai G; Vaughn S; Zhang Y; Wang ET; Garcia-Cardena G; Gimbrone MA
    Circ Res; 2007 Sep; 101(7):723-33. PubMed ID: 17673673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.